LOC144097_AI846148 Inhibitors
LOC144097_AI846148 inhibitors encompass a range of compounds that act upon various signaling pathways to indirectly influence the activity of LOC144097_AI846148. The primary focus of these inhibitors is on kinases and signaling molecules that, when inhibited, could lead to decreased phosphorylation states of proteins, reduced signal transduction, and altered cellular responses that ultimately affect the function of LOC144097_AI846148. For instance, Src family kinases are critical for multiple signaling pathways, and their inhibition by compounds such as PP2 and Dasatinib can lead to reduced activation of proteins that depend on Src signaling. This could decrease the functional activity of LOC144097_AI846148, especially if its activity or stability is contingent upon phosphorylation events mediated by these kinases.
Moreover, the modulation of specific kinase activities by inhibitors such as Gö6976, LY333531, PD173074, and SP600125 showcases the diverse mechanisms by which the activity of LOC144097_AI846148 can be indirectly diminished. PKC, as a signaling molecule, plays a crucial role in various cellular pathways, and thus, inhibitors targeting PKC isoforms can interfere with downstream signaling events. For LOC144097_AI846148, which may be regulated by PKC-dependent phosphorylation, inhibitors like Gö6976 and LY333531 can lead to a decrease in its activity. This outcome could also be a consequence of inhibiting other kinases such as JNK with SP600125, which would reduce the phosphorylation state of LOC144097_AI846148 if it is a substrate of JNK. Similarly, SB203580 and U0126 target the MAPK pathway, a pivotal signaling cascade in cellular processes, and by inhibiting this pathway, they can suppress the activity of downstream effectors like LOC144097_AI846148.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor that impairs the Src kinase signaling involved in various cellular processes. Inhibition of Src kinase by PP2 can lead to reduced phosphorylation of downstream effectors, potentially impairing the function of LOC144097_AI846148 if it relies on Src-mediated signaling for activation or stabilization. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
This is a multi-targeted inhibitor, known to block Bcr-Abl and Src family kinases. Dasatinib's inhibition of Src kinases can decrease phosphorylation activities that might be essential for LOC144097_AI846148's functional state, particularly if it plays a role in signal transduction pathways that rely on Src signaling. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
A potent protein kinase C (PKC) inhibitor that could inhibit the PKC-dependent signaling pathways. If LOC144097_AI846148 is involved in pathways regulated by PKC, then Gö6976 can lead to reduced activation of LOC144097_AI846148 by preventing its phosphorylation by PKC. | ||||||
LY-333,531 Hydrochloride | 169939-93-9 | sc-364215 sc-364215A | 1 mg 5 mg | $94.00 $287.00 | 6 | |
A specific inhibitor of protein kinase C beta (PKCβ), which can affect the PKC-mediated signaling. If LOC144097_AI846148's activity is modulated via PKCβ, then LY333531 can lead to decreased phosphorylation and hence reduced activity of LOC144097_AI846148. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
A specific inhibitor of the Fibroblast Growth Factor Receptor (FGFR) tyrosine kinase. By inhibiting FGFR, PD173074 can affect downstream signaling pathways, potentially leading to reduced activity of LOC144097_AI846148 if it is regulated by FGFR-mediated pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An anthrapyrazolone inhibitor that selectively inhibits c-Jun N-terminal kinase (JNK). If LOC144097_AI846148 is activated by JNK signaling, inhibition by SP600125 can lead to decreased activity of the protein. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A pyridinyl imidazole inhibitor that selectively inhibits p38 MAPK. If LOC144097_AI846148 functions downstream of p38 MAPK, then SB203580 can reduce its activity by inhibiting the signaling required for its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that prevents the formation of phosphatidylinositol (3,4,5)-trisphosphate (PIP3). If LOC144097_AI846148 requires PIP3 or PI3K-dependent signaling for its function, then LY294002 can inhibit its activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An inhibitor of MEK1/2, which prevents the activation of the ERK pathway. If LOC144097_AI846148's function is regulated through the MAPK/ERK pathway, then U0126 can lead to a decrease in its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that affects the mTOR signaling pathway. Inhibition of mTOR by Rapamycin can decrease the activity of LOC144097_AI846148 if it is involved in pathways that are regulated by mTOR. | ||||||